Daniel Clark
Stock Analyst at Leerink Partners
(3.76)
# 2,034
Out of 5,133 analysts
55
Total ratings
74.1%
Success rate
13.6%
Average return
Main Sectors:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals | Reiterated: Buy | $23 → $25 | $21.38 | +16.93% | 3 | Nov 5, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $20 | $6.84 | +192.40% | 1 | Nov 5, 2026 | |
| PHAT Phathom Pharmaceuticals | Reiterated: Hold | $10 → $7.5 | $6.06 | +23.76% | 2 | Nov 2, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Buy | $24 → $26 | $21.09 | +23.28% | 2 | Oct 29, 2026 | |
| PCRX Pacira BioSciences | Reiterated: Hold | $28 → $37 | $36.46 | +0.11% | 2 | Oct 9, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | $30 → $34 | $26.78 | +26.96% | 15 | Oct 1, 2026 | |
| ZTS Zoetis | Reiterated: Hold | n/a | $83.82 | - | 13 | Oct 1, 2026 | |
| ANIP ANI Pharmaceuticals | Initiated Coverage: Buy | $104 | $71.44 | +45.58% | 1 | Sep 9, 2026 | |
| COLL Collegium Pharmaceutical | Initiated Coverage: Buy | $45 | $25.32 | +77.73% | 1 | Sep 9, 2026 | |
| HROW Harrow | Initiated Coverage: Buy | $45 | $30.12 | +49.40% | 1 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $20.82 | -3.94% | 1 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $745 → $785 | $704.23 | n/a | 13 | Nov 3, 2025 |
Amneal Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $23 → $25
Current: $21.38
Upside: +16.93%
Solid Biosciences
Nov 5, 2026
Reiterated: Buy
Price Target: $20
Current: $6.84
Upside: +192.40%
Phathom Pharmaceuticals
Nov 2, 2026
Reiterated: Hold
Price Target: $10 → $7.5
Current: $6.06
Upside: +23.76%
Bausch + Lomb
Oct 29, 2026
Reiterated: Buy
Price Target: $24 → $26
Current: $21.09
Upside: +23.28%
Pacira BioSciences
Oct 9, 2026
Reiterated: Hold
Price Target: $28 → $37
Current: $36.46
Upside: +0.11%
Elanco Animal Health
Oct 1, 2026
Reiterated: Buy
Price Target: $30 → $34
Current: $26.78
Upside: +26.96%
Zoetis
Oct 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $83.82
Upside: -
ANI Pharmaceuticals
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $104
Current: $71.44
Upside: +45.58%
Collegium Pharmaceutical
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $25.32
Upside: +77.73%
Harrow
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $30.12
Upside: +49.40%
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $20.82
Upside: -3.94%
Nov 3, 2025
Reiterated: Buy
Price Target: $745 → $785
Current: $704.23
Upside: n/a